SHANGHAI, China, March 23, 2009 — Praxair China has signed a contract with Hebei Baiqi Pharmaceutical Co., Ltd. (Baiqi) to supply nitrogen for its pharmaceutical production requirements.
Baiqi will use nitrogen for blanketing and inerting the production process which will result in increased drying efficiency as well as improved functionality and safety performance of the reactor.
“This is an important contract in our relationship with Hebei Baiqi Pharmaceutical and demonstrates our technical capability to support energy saving in the pharmaceutical industry,” commented David Chow, president of Praxair China.
About Praxair China
Praxair (China) Investment Co., Ltd is a leading industrial gas provider in China. It is headquartered in Shanghai, has 17 wholly owned companies, 10 joint ventures and over 1200 employees in the country. More information on Praxair China is available on the Internet at www.praxair.cn.
Praxair, Inc. (NYSE: PX) is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2008 sales of $10.8 billion. The company produces, sells and distributes atmospheric, process and specialty gases, and high-performance surface coatings. Praxair products, services and technologies bring productivity and environmental benefits to a wide variety of industries, including aerospace, chemicals, food and beverage, electronics, energy, healthcare, manufacturing, metals and others. More information on Praxair is available on the Internet at www.praxair.com.